medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2019; 47 (1)

Segmental neurofibromatosis

Rossello VE, López GVR, Blanzari MJ, Andres G, del Valle PMB
Full text How to cite this article

Language: Spanish
References: 10
Page: 65-67
PDF size: 279.67 Kb.


Key words:

Segmental neurofibromatosis, mosaicism, neurofibromas.

ABSTRACT

Neurofibromatosis type 1 (NF-1) is an autosomal inherited neurocutaneous disease with an incidence rate of 3,000-5,000 live births. Segmental neurofibromatosis (NFS) is a form of NF-1. NFS is caused by postzygotic NF-1 gene mutations, where patients’ typical characteristics are limited to one or more body segments, without systemic implications. We present the case of a patient with NFS and neurofibromas located in the lumbosacral region as a single manifestation of the disease.


REFERENCES

  1. Chu CH, Chou TC, Liu CI, Hsu CS et al. Multiple segmental neurofibromatosis: report of two cases with different presentations. Hong Kong J Dermatol Venereol. 2016; 24: 34-39.

  2. Choen PR. Segmental neurofibromatosis and cancer: report of triple malignancy in a woman with mosaic neurofibromatosis 1 and review of neoplasms in segmental neurofibromatosis. Dermatol Online J. 2016; 22 (7).

  3. Campollo-Rodríguez I, Rodríguez-Rojas JL, Limache-Yaringaño LM. Neurofibromatosis segmentaria: presentación de un caso. AMC. 2011; 15 (6).

  4. Wu J, Zhao J, Tian W. Segmental neurofibromatosis of the upper extremity: a case report. J Hand Surg Eur. 2015; 40 (6): 640-641.

  5. Abdolrahimzadeh S, Piraino DC, Plateroti R, Scuderi G et al. Ocular alterations in a rare case of segmental neurofibromatosis type 1 with a non-classified mutational variant of the NF-1 gene. Ophthalmic Genet. 2016; 37 (2): 214-216.

  6. Rosmaninho A, Carvalho S, Oujo E, Horta M. Syndrome in question. An Bras Dermatol. 2016; 91 (2): 245-247.

  7. McLimore H, McCaughey C, Vanness E. A case of late-onset segmental neurofibromatosis. WMJ. 2014; 113 (2): 72-73.

  8. Marmottant-Debled E, Chiaverini C, Fossoud C, Passeron T et al. Evaluation of learning disabilities in segmental neurofibromatosis. British Journal of Dermatology. 2016; 174: 1404-1406.

  9. Jang HW, Ryu HJ, Kim IH, Son SW. Segmental neurofibromatosis with visceral neurofibromas. Annals of Dermatology. 2016; 28 (2): 253-254.

  10. Guillén-Navarro E, Ballesta-Martínez MJ, Galán-Gómez E. Protocolo de seguimiento de la neurofibromatosis tipo 1. Protoc Diagn Pediatr. 2010; 1: 44-50.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2019;47